Sutterella parvirubra

Information

Microbe Identification

Sutterella parvirubra

Microbe id: PMDBM2021369
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Sutterella parvirubra [437898]
Taxonomy Genus: Sutterella [40544]
Taxonomy Family: Sutterellaceae [995019]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Sutterella parvirubra

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
Unclassified gene clusterTrimethylamine / nitrateMolybdopterin dependent oxidoreductasePMID: 1917829 / PMID: 2674654
Unclassified gene clusterFumarateFumarate to succinatePMID: 28049145

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Sutterella parvirubra


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Aryl polyenesAryl polyenesArylpolyenePMID: 30908039

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Sutterella parvirubra distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Sutterella parvirubra in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Sutterella parvirubra

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Hypertension PRJNA509999🔗-3.53148463831991mNGS
Diabetes Mellitus, Type 2 PRJNA646010🔗2.4512622078304416S
Diarrhea PRJNA317326🔗-3.4938299552358316S
Diarrhea PRJEB14038🔗-3.4317122771818mNGS
Colorectal Neoplasms PRJNA986175🔗-4.1202668426314316S
Colorectal Neoplasms PRJEB46665🔗-3.0210799521183216S
Lupus Erythematosus, Systemic PRJEB39044🔗3.4504826732962316S
Gastrointestinal Diseases PRJNA917086🔗3.2029230156487716S
Tuberculosis PRJNA795263🔗-2.9676337124885716S
Hepatitis, Viral, Human PRJNA540738🔗-3.6376907098127116S
Hepatitis, Autoimmune PRJNA556801🔗-3.9796525082784216S
Colitis, Ulcerative PRJNA813736🔗-3.83089721644443mNGS
Colitis, Ulcerative PRJNA398089🔗-3.41912702962777mNGS
Colitis, Ulcerative PRJNA993675🔗-3.39723539910788mNGS
Campylobacter Infections PRJNA660443🔗-3.86792380522225mNGS
Carcinoma, Hepatocellular PRJNA872871🔗-4.1272684077197716S
Celiac Disease PRJNA890948🔗3.8903896159157416S
Hepatolenticular Degeneration PRJNA1038771🔗-3.4021487996491816S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.7629882149900916S
Non-alcoholic Fatty Liver Disease PRJNA540738🔗-3.4747482319725816S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗3.7408121277612416S
Prostatic Neoplasms PRJNA762994🔗-3.478604785318816S
Schizophrenia PRJNA1135717🔗3.73494524371865mNGS
Tic Disorders PRJNA780788🔗-3.3668888141679416S
Crohn Disease PRJNA813736🔗-3.84713040367286mNGS
Crohn Disease PRJNA793776🔗-3.52907216520356mNGS
Crohn Disease PRJNA993675🔗-3.17957091312885mNGS
Crohn Disease PRJNA398089🔗3.75777467294207mNGS
Psoriasis PRJNA938297🔗-2.76960465442171mNGS
Schistosomiasis haematobia PRJNA526732🔗-2.048662152756216S
Purpura, Thrombocytopenic, Idiopathic PRJNA531564🔗-3.5097567935296116S
Cholestasis PRJNA540738🔗-3.7837322922497416S
Cholestasis PRJNA478781🔗3.4430334402489816S
Moyamoya Disease PRJNA917033🔗-3.1612448589459116S
Arthritis, Rheumatoid PRJNA896336🔗-3.56174568695617mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗-3.79788315073213mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-3.32970779519556mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗3.51431139940955mNGS
Gallstones PRJNA822035🔗-3.5579907270354616S
Cholangiocarcinoma PRJNA932948🔗2.85587291263073mNGS
Myasthenia Gravis PRJNA688881🔗3.59030965000956mNGS
Myasthenia Gravis PRJNA450610🔗4.2084122989226216S
Irritable Bowel Syndrome PRJEB37924🔗-3.14149630738219mNGS
Irritable Bowel Syndrome PRJNA682378🔗3.0263047120668916S
Amyotrophic Lateral Sclerosis PRJEB32767🔗-3.53199121534121mNGS
Diabetes, Gestational PRJNA994318🔗-3.68146406954114mNGS
Lung Neoplasms PRJNA736821🔗-3.6076673125395216S
Obesity PRJNA1125836🔗-4.15736941574523mNGS
Diabetes Mellitus PRJNA774037🔗-4.0557257492910216S
Autism Spectrum Disorder PRJEB42687🔗-3.7663515924937316S
Neuromyelitis Optica PRJNA422961🔗-4.1157178250110816S
Neuromyelitis Optica PRJNA662563🔗-3.612509283753816S
Inflammatory Bowel Diseases PRJEB13266🔗-3.7201354184355616S
Hand, Foot and Mouth Disease PRJNA1017976🔗3.8372233362507616S
Rhinitis, Allergic PRJNA718687🔗-3.7416238765902516S
Renal Insufficiency, Chronic PRJNA949558🔗-3.7297913659237216S
Renal Insufficiency, Chronic PRJNA562327🔗-3.5713707740581816S
Multiple Sclerosis PRJNA721421🔗2.4071854486373416S
Malaria PRJNA642859🔗-3.5606439236702816S
Fibromyalgia PRJNA521587🔗-3.74705492319811mNGS
COVID-19 PRJNA767939🔗-4.2053053396118516S
COVID-19 PRJNA769052🔗-3.7747450903587716S
COVID-19 PRJNA689961🔗3.44412349793084mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Sutterella parvirubra



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Sutterella parvirubra



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Sutterella parvirubra

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
1Sutterella_parvirubra_YIT_11816 Download

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Sutterella parvirubra


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Sutterella parvirubra



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Sutterella parvirubra

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Sutterella parvirubra

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Sutterella parvirubra

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
1Sutterella_parvirubra_YIT_11816 View

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Sutterella parvirubra



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Sutterella parvirubra


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Sutterella parvirubra


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?